Gamma-glutamyl Transferase in Adults
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Texas Policy RPLAB056 alerts
Get alerted when Policy RPLAB056 changes without checking for updates manually.
Monitor payer policy activity
This reimbursement policy governs when serum gamma-glutamyl transferase (GGT) testing may be reimbursable for individuals age 18 or older. It allows limited-frequency testing for specified clinical indications and excludes testing during asymptomatic wellness or general examinations without abnormal findings.
The policy added that primary or secondary malignant neoplasms must involve the digestive system to support the specified GGT testing criterion.
The criterion for assessing liver function after liver transplantation was revised for clarity.
The policy added a clarification that the reimbursement criteria apply only to individuals age 18 years or older.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.